Novo Nordisk LinkedIn - Search News

News

Novo Nordisk shares dip further

Reuters on MSN · 21h

Novo Nordisk shares dip further as Wegovy gains nearly erased

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent losses that threaten to wipe out all the gains since the drugmaker launched its blockbuster weight-loss treatment Wegovy four years ago.

QuickTake on MSN · 1d

How Novo Nordisk Gave Up Its Weight-Loss Gains

How did Novo lose its edge in the weight-loss market? Novo was a first mover when it comes to so-called GLP-1 treatments, which cause weight loss by mimicking the appetite-control

Hosted on MSN · 1d

Novo Nordisk shares extend losses, erasing nearly all gains since Wegovy launch

(Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday to their lowest since August 2021, extending recent losses to wipe out almost all the gains made since the drugmaker launched its blockbuster weight-loss treatment Wegovy.

2don MSN

Novo CEO’s First Test Is Winning Back the US Weight-Loss Market

Novo Nordisk A/S’s best-sellers Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years ...

2don MSN

Novo Nordisk slides further on US competition, new CEO concerns

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs ...

Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%

In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its ...

3don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results